| Neptune Signs World Wide Catalogue Distribution Agreement with Bronson Laboratories |
| Tuesday, September 27 2005 | |||
Neptune Signs World Wide Catalogue Distribution Agreement with Bronson LaboratoriesLaval Quebec CANADA, September 27, 2005 – Neptune Technologies & Bioressources Inc. (TSX-V:NTB), active in the field of high value-added natural product extraction from marine biomasses, such as krill, is pleased to announce that Bronson Laboratories launches Neptune Krill Oil, (NKO™), under the Bronson brand name. For over 44 years, Bronson Laboratories has been a “factory-direct” source of top-quality nutritional supplements, including vitamins, minerals, herbs, specialized formulas, and health & body care products. Bronson products are backed, used and prescribed by more health care professionals than any other brand and have been consistently recommended by foremost nutritional scientists such as Nobel Prize winner Linus Pauling and many other notable experts. As a result, Bronson has grown to become one of the largest and most respected “direct-to-consumer” manufacturers and marketers of over 400 nutritional supplements. Bernard Giguère, Vice President, Sales and Marketing, at Neptune Technologies & Bioressources stated, “This agreement is significant to Neptune due to Bronson’s 44-year heritage, track record, extensive knowledge, credibility and strong sales force.” Mr. Giguère continued to say, “The Bronson team has completed an incredible marketing plan for the launch of their new product with NKO™ and we look forward to becoming an important component of their catalogue offering.” This press release is available on the Company's on-line Investor Relations site for investor commentary, feedback and questions. Investors are invited to visit http://www.agoracom.com/ and select the Neptune Technologies Information and Contact Forum, or link directly to it at http://www.agoracom.com/nonmemforum/main.asp?topic=neptune+technologies&tr; Investors are also invited to e-mail any questions regarding the Company directly to This e-mail address is being protected from spambots, you need JavaScript enabled to view it Potential investors may also use this address to request being added to the Neptune Technologies investor e-mail list. Neptune Technologies & Bioressources Inc. https://www.neptunebiotech.com/ FORWARD-LOOKING STATEMENTS: Neptune Technologies and Acasti Pharma Contact:
Neptune Technologies & Bioressources Inc. Acasti Pharma Inc. Toni Rinow, Ph.D., MBA Corporate Development & Investor Relations (450) 687-2262 This e-mail address is being protected from spambots, you need JavaScript enabled to view it
|